Who We Are

The COGNID was established in 2025 to strengthen international collaboration in diabetes and cognitive health. 

COGNID provides a platform for researchers and healthcare professionals interested in understanding how diabetes influences brain health across the lifespan. The group brings together expertise from diabetology, neurology, epidemiology, neuroscience, geriatrics, psychology, and other related disciplines.

Through collaborative research, scientific exchange, education, and advocacy, COGNID aims to address important unanswered questions and support the development of evidence-based approaches for the prevention, detection, and management of cognitive dysfunction in people with diabetes.